Friedman Franklin Stuart 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Friedman Franklin Stuart
Director
Transactions
- Purchase
Common Stock
2023-06-08$13.88/sh+10,000$138,828→ 10,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.87 to $13.89, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.